quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:49:24·1113d
NEWSRelease
AbbVie Inc. logo
iShares Nasdaq Biotechnology Index Fund logo
Thermo Fisher Scientific Inc logo

AbbVie, Thermo Fisher Scientific And A Must-Watch Biotech ETF: CNBC's 'Final Trades'

ABBV· AbbVie Inc.IBB· iShares Nasdaq Biotechnology Index FundTMO· Thermo Fisher Scientific Inc
Health CareIndustrials
Original source

Companies

  • ABBV
    AbbVie Inc.
    Health Care
  • IBB
    iShares Nasdaq Biotechnology Index Fund
    n/a
  • TMO
    Thermo Fisher Scientific Inc
    Industrials

Recent analyst ratings

  • Apr 21ABBVUpdateCanaccord Genuity$262.00
  • Mar 27TMOUpdateDZ Bank$610.00
  • Feb 25ABBVUpdateRBC Capital Mkts$260.00
  • Feb 20ABBVUpdateBarclays$275.00
  • Jan 8ABBVUpdateWolfe Research-
  • Jan 7ABBVUpdateUBS$240.00

Related

  • PR11h
    AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
  • SEC21h
    Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR21h
    Thermo Fisher Scientific Reports First Quarter 2026 Results
  • PR1d
    AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus
  • ANALYST2d
    Canaccord Genuity initiated coverage on AbbVie with a new price target
  • PR3d
    AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada
  • PR9d
    Erin Lichy Gets Real About Her Natrelle® Breast Augmentation
  • PR11d
    Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022